AJP - Lung Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 295: L727-L732, 2008. First published August 22, 2008; doi:10.1152/ajplung.90354.2008
1040-0605/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/L727    most recent
90354.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez-Lopez, J. G.
Right arrow Articles by Perez-Vizcaino, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez-Lopez, J. G.
Right arrow Articles by Perez-Vizcaino, F.

EDITORIAL FOCUS

Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction

Jose G. Lopez-Lopez,1 Javier Moral-Sanz,2 Giovanna Frazziano,2 Maria J. Gomez-Villalobos,1 Jorge Flores-Hernandez,1 Eduardo Monjaraz,1 Angel Cogolludo,2 and Francisco Perez-Vizcaino2

1Instituto de Fisiologia, Universidad Autonoma de Puebla, Puebla, Mexico; and 2Departamento de Farmacología, Facultad de Medicina, Universidad Complutense Madrid and Ciber Enfermedades Respiratorias (CibeRes), Madrid, Spain

Submitted 18 June 2008 ; accepted in final form 18 August 2008

Recent data suggest that diabetes is a risk factor for pulmonary hypertension. The aim of the present study was to analyze whether diabetes induces endothelial dysfunction in pulmonary arteries and the mechanisms involved. Male Sprague-Dawley rats were randomly divided into a control (saline) and a diabetic group (70 mg/kg–1 streptozotocin). After 6 wk, intrapulmonary arteries were mounted for isometric tension recording, and endothelial function was tested by the relaxant response to acetylcholine. Protein expression and localization were measured by Western blot and immunohistochemistry and superoxide production by dihydroethidium staining. Pulmonary arteries from diabetic rats showed impaired relaxant response to acetylcholine and reduced vasoconstrictor response to the nitric oxide (NO) synthase inhibitor L-NAME, whereas the response to nitroprusside and the expression of endothelial NO synthase remained unchanged. Endothelial dysfunction was reversed by addition of superoxide dismutase or the NADPH oxidase inhibitor apocynin. An increase in superoxide production and increased expression of the NADPH oxidase regulatory subunit p47phox were also found in pulmonary arteries from diabetic rats. In conclusion, the pulmonary circulation is a target for diabetes-induced endothelial dysfunction via enhanced NADPH oxidase-derived superoxide production.

pulmonary arteries; superoxide; nitric oxide; streptozotocin



Address for reprint requests and other correspondence: F. Perez-Vizcaino, Departamento de Farmacología, Facultad de Medicina, Universidad Complutense Madrid, 28040 Madrid, Spain (e-mail: fperez{at}med.ucm.es)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Gao and G. E. Mann
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Cardiovasc Res, April 1, 2009; 82(1): 9 - 20.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Fouty
Diabetes and the pulmonary circulation
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L725 - L726.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.